Learning Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 3 Component(s), Includes Credits Includes a Live Web Event on 07/06/2022 at 4:30 PM (EDT)

    ​With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    With the growing recognition of the infection risks of peripheral intravenous catheters (PIVC), many hospitals are implementing PIVC insertion and maintenance bundles. This presentation will review the evidence for PIVC bundles, discuss the essential components for such a bundle, explore implementation challenges, and emphasize compliance strategies. Infusion nurses who are considering implementing a PIVC insertion or maintenance bundle will benefit from this presentation.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    1.     Describe the common reasons for PIVC failure and the prevalence of PIVC bloodstream infection.

    2.     Review the history and rationale of the evidence-based bundle for bloodstream infection reduction.

    3.     Discuss the rationale for implementing a PIVC insertion and maintenance bundle.

    4.     Identify bundle components which have demonstrated reductions in PIVC–related bloodstream infection and other adverse events.

    5.     Discuss the challenges of bundle implementation and possible strategies to achieve compliance.

    Gillian Ray-Barruel, PhD, RN

    Senior Research Fellow

    University of Queensland School of Nursing, Midwifery, and Social Work

    Gillian Ray-Barruel, PhD, RN, is a senior research fellow with the University of Queensland School of Nursing, Midwifery, and Social Work and the Herston Infectious Diseases Institute (HeIDI), and an adjunct senior research fellow with Griffith University in Brisbane, Australia. She is also the education director for the Alliance for Vascular Access Teaching and Research (AVATAR). An experienced critical care nurse for 20 years, Dr. Ray-Barruel moved into vascular access research over 10 years ago and has published over 60 journal articles. Her research focuses on improving assessment and decision-making by clinicians to prevent device-related patient complications and to improve health care outcomes.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: July 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 3 Component(s), Includes Credits Recorded On: 06/15/2022

    ​Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    image

    Management of hypersensitivity infusion reactions (IRs) with H1-antihistamine premedication and/or treatment is recommended for several biologics and chemotherapies used in infusion centers. The sole second-generation intravenous H1-antihistamine recommended is cetirizine. In this session, the presenter will review key clinical data available with IV cetirizine as well as clinical profiles of first- and second-generation H1 antihistamines used to manage infusion reactions.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    • Explain various infusion reactions and antihistamine use

    • Determine infusion reactions requiring a H1-antihistamine to treat a reaction or to prevent future reactions

    • Describe the use of IV H1-antihistamines

    • Determine which treatment options are the most appropriate for certain patients

    Ryan Haumschild, PharmD, MS, MBA

    Ryan Haumschild, PharmD, MS, MBA, is an experienced director of pharmacy, overseeing profit and loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use at the Winship Cancer Institute at Emory University, one of the nation’s largest academic integrated delivery networks and Georgia’s only National Cancer Institute (NCI)–designated comprehensive cancer center. Dr. Haumschild provides strategic direction on oncology and nononcology disease states, on infusion and specialty pharmacy services, and on the expansion of clinical services through treatment pathway development. He currently serves as an editorial board member at the American Journal of Managed Care® (AJMC®) and as a board member for the Institute of Safe Medication Practices (ISMP) and for the Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 15, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 16 Product(s)

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.

    INS 2022 Virtual Conference will provide a great alternative for those who are not able to attend the in-person event. Participants will have the ability to attend 15 select sessions virtually and on-demand. This option also enables CRNI®s to earn up to 30 recertification (RU) units. The virtual program will include the 5-hour veINS focus track on Monday, June 6 plus 10 additional one-hour sessions on Sunday, June 5.  

  • Contains 3 Component(s), Includes Credits Recorded On: 05/18/2022

    ​There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    There are many different forms of infusions that are administered to infants and children, and many are life-saving. However, they are also not without the potential for serious complications and morbidity. Infusion nurses are at the forefront of promoting safe, high-quality practices to prevent harm from this vital therapy. In this webinar, we will explore the strategies infusion nurses can employ to reduce harm to pediatric patients at their organization.

    Learning Objectives: At the conclusion of this webinar, learners will be able to: 

    ·      Describe the ethical duty of beneficence when caring for a patient receiving infusion therapy

    ·      Discuss two types of infusion injuries that have high-morbidity outcomes

    ·      List four strategies the infusion nurse can employ to reduce harm to the pediatric patient receiving infusion therapy at their organization

    Kristina Burger, DNP, APRN, CPNP-PC, CCRN, NPD-BC, LNC

    Dr. Kristina Burger has practiced pediatric nursing for 35 years and in a variety of settings from critical care to home care. She has provided extensive staff development on infusion therapy to all levels of nurses from new graduates to those providing home infusion services. She has also written numerous policies on infusion therapy and recently published a research paper testing the validity and reliability of a pediatric infiltration/extravasation staging tool with colleagues from Johns Hopkins All Children's Hospital.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: May 18, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 1 Component(s)

    Plasma is a vital source material for a number of plasma-derived medications that treat and prevent life-threatening diseases, illnesses and conditions. Plasma can’t be created in a laboratory or synthetically produced. Learn how plasma donation helps make therapies available for patients with bleeding disorders, Alpha-1antitrypsin deficiency, Guillain-Barre syndrome, infections and many other conditions.

    image

    Plasma is a vital source material for a number of plasma-derived medications that treat and prevent life-threatening diseases, illnesses and conditions. Plasma can’t be created in a laboratory or synthetically produced. Learn how plasma donation helps make therapies available for patients with bleeding disorders, Alpha-1antitrypsin deficiency, Guillain-Barre syndrome, infections and many other conditions.

    Vlasta Hakes

    Senior Director, Corporate Affairs

    Grifols

    Vlasta leads Grifols ongoing efforts to develop and execute social initiative strategies that advance Grifols brand and reputation in the communities in which Grifols operates. Her key responsibilities include ensuring that these activities align with and advance Grifols corporate mission, build shared value with core stakeholders, and increase internal and external engagement in the Company’s social programs. By understanding both the needs of the business and local communities in which Grifols operates, she is able to drive innovative approaches to Grifols’ corporate sustainability strategy that highlight Grifols brand and reputation as a world-class company.

    Vlasta proudly serves as a Board Member of the J.A. Grifols Foundation along with managing the growth and day-to-day activities of the Foundation. She is also a steering member of the Women's Leadership Initiative, a Grifols Employee Resource Group.

    Vlasta joined Grifols in December 2006 and is based in Washington D.C. She graduated with a Masters of Arts in Political Management from George Washington University, Washington D.C. Vlasta also holds a Bachelor of Arts in Political Science and Speech Communications from the University of Illinois, Urbana Champaign. 

    Host: Dawn Berndt, DNP, RN, CRNI® - Clinical Education and Publications Manager

    Guest: Vlasta Hakes, Senior Director, Corporate Affairs - Grifols

    Plasma is a vital source material for a number of plasma-derived medications that treat and prevent life-threatening diseases, illnesses and conditions. Plasma can’t be created in a laboratory or synthetically produced. Learn how plasma donation helps make therapies available for patients with bleeding disorders, Alpha-1antitrypsin deficiency, Guillain-Barre syndrome, infections and many other conditions.

     Resources:

    ·       www.grifols.com (general information about Grifols)

    ·      www.grifolsplasma.com (general information about Grifols plasma donor centers, what you need when you donate, etc)

    ·      https://www.grifolsplasma.com/en/locations/find-a-donation-center (link to where to find a plasma donation center)

    ·      https://www.grifolsplasma.com/en/plasma-donor/why-donate

    ·      https://www.grifolsplasma.com/en/about-plasma-donation/what-is-plasma

  • Contains 1 Component(s)

    Interested in learning how to improve ultrasound assessment and needle insertion skills? Attend the INS preconference workshop and learn from national experts about topics that impact your practice including intraosseous access, device selection, care, management, and salvage. This program is sponsored by Teleflex Incorporated.

    image

    Interested in learning how to improve ultrasound assessment and needle insertion skills? Attend the INS preconference workshop and learn from national experts about topics that impact your practice including intraosseous access, device selection, care, management, and salvage. This program is sponsored by Teleflex Incorporated.  

    Dr. Amy Bardin-Spencer Ed.D, MSc, RRT, VA-BC, FAARC

    I am a member of a dynamic team stretching the boundaries of skill and scope of practice in the name of patient care and positive outcomes. As a proud respiratory therapist and vascular access specialist I really have the best of both worlds. I am able to maintain a passion in my chosen field of respiratory care and advance a scope to increase collaboration among an entire healthcare team to deliver better practice with measurable related outcomes. In the last few years, I have focused on advancing my education, having completed my BS and MS I am now pursuing my PhD. This journey has been amazing and has opened my mind to so many great things. Sticking to my personal moto of “Find your Purpose,” I have truly found mine as both a bedside clinician and a teacher/mentor. 

     My philosophy regarding teaching and mentoring others encompasses the ability to contribute to someone else’s success, through motivation, inspiration and leading by example. Working side by side with individuals or an entire team and finding common practices that exemplify our work and patient outcomes. As a teacher/mentor/leader I believe motivation is important, maintaining a vision and expectation is essential for others success. Inspiring each individual to their maximum potential by seeking qualities within them. I am a leader, leading individuals on my team or in life through a journey of personal experience and contribution, reward, and challenge.

    Amy Mills, RN

    Amy Mills is an experienced nurse of 29 years with clinical experience in neonatal intensive care, pediatric intensive care, emergency department and air medical transport. Currently, she is the Senior Manager of Strategic Programs with Clinical Affairs at Teleflex. Amy takes pride in providing the best clinical education possible and has a goal to make a positive impact on patient care through research, education, and clinical support.

    In her role, Amy develops and delivers clinical education from novice to expert, engages in research to support the development of new products and the expansion of clinical practice, and collaborates with medical societies on innovative education programs. Engagement with societies brings a high-level of connection to the bedside nurse which is one of the things Amy likes best about this interaction, as she is always thinking of new and exciting ways to bring education to life.

    Amy is the recipient of the prestigious Brody Award for Nursing Excellence. This annual award is given to one Divisional Staff Nurse of the Year at Vidant Medical Center. This award was achieved after a year of dedication to pediatric trauma pain management research, development of a flight team skills maintenance program and publication of previous research in the hospital journal. These were the stepping-stones of Amy’s career, which has a parallel path at Teleflex.

    When not developing or delivering education, you can find Amy spending time with her large family to include her husband, son, and golden retriever. She also enjoys giving back to her community as a volunteer for charitable services.

               

    Marlene Steinheiser, PhD, RN, CRNI®

    Director of Clinical Education, INS

    Marlene Steinheiser, PhD, RN, CRNI®, is the Director of Clinical Education for INS. In her role, she directs the development of educational programs and resources for INS and develops strategic alliances with other organizations. She earned her PhD in nursing at the University of Arizona, conducting research focusing on compassion fatigue among healthcare professionals. A nurse for more than 32 years, Dr. Steinheiser has had experience in acute care, home infusion, long-term care, regulatory organizations, and academic nursing.

    Host: Dawn Berndt, DNP, RN, CRNI® – INS Clinical Education and Publications Manager

    Guests:

    ·       Dr. Amy Bardin-Spencer,  EdD, MSc, RRT, VA-BC, FAARC – Director, Medical Affairs and Senior Director, Clinical Affairs, Vascular at Teleflex Incorporated

    ·       Amy Mills, BSN, RN – Senior Manager, Clinical Affairs at Teleflex Incorporated

    ·       Marlene M. Steinheiser, PhD, RN, CRNI®– INS Director of Clinical Education

    Interested in learning how to improve ultrasound assessment and needle insertion skills? Attend the INS preconference workshop and learn from national experts about topics that impact your practice including intraosseous access, device selection, care, management, and salvage. This program is presented by Teleflex Clinical and Medical Affairs.  

    Special INS 2022 Preconference Workshop Offered on Friday, June 3, 1:00–5:00pm

    Right Line Right Now. Presented by Teleflex Clinical and Medical Affairs

    This 4-hour workshop will explore vascular access options for patients with urgent, emergent, and long-term access needs. Selection of the right device for each clinical situation using the latest innovations in both intraosseous (IO) and intravenous access will be explored as will anatomical characteristics of the vasculature using ultrasound guidance.

    6 hands-on clinical stations will include:

    1. Ultrasound Assessment
    2. Ultrasound Needling
    3. Care and Management
    4. Device Selection
    5. Device Salvage
    6. Intraosseous Access

    This workshop requires a separate registration fee and is limited to 48 participants.

    Don’t delay. Click here to secure your ticket!

    Resources:

    Vascular Access | US | Teleflex

    Right Line Right Now Preconference Workshop

    INS 2022 Annual Conference at the Rosen Shingle Creek Resort in Orlando, Florida

  • Contains 3 Component(s), Includes Credits Recorded On: 04/06/2022

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Infusion nurses play a vital role in inquiry work because they are uniquely able to identify opportunities for improvement in infusion therapy practice or potential patient safety problems. This webinar will provide an overview of inquiry and discuss the differences between the three types of inquiry including evidence-based practice (EBP), quality improvement (QI), and research. The basic evidence-based process will be examined, and participants will be introduced to three common EBP models. Resources to promote infusion nurse participation in inquiry and dissemination will also be explored.

    Learning objectives: At the completion of this webinar, learners will be able to:

    1.     Discuss the basic differences between evidence-based practice, quality improvement, and research

    2.     Describe the basic evidence-based practice process

    3.     State at least one common evidence-based practice model

    4.     Describe resources available to promote infusion nurse participation in inquiry and dissemination

    Genieveve Cline, PhD, DNP, APRN, NNP-BC, CNE, NPD-BC

    Assistant Professor, Director of the Education Concentration

    University of South Florida, College of Nursing

    Dr. Genieveve Cline is an assistant professor at the University of South Florida, College of Nursing, and the director of the education concentration. Dr. Cline graduated with her PhD as a nurse research scientist in 2018 from the University of South Florida, and received her Doctorate of Nursing Practice from the University of South Florida in 2009. She is certified as a neonatal nurse practitioner, an academic educator, and a nursing professional development specialist. She currently teaches research, evidence-based practice, organizational and systems leadership, and quality improvement in the graduate nursing program in addition to teaching the nurse educator curriculum. Prior to her current position, Dr. Cline was the director of nursing research and evidence-based practice at Johns Hopkins All Children's Hospital and taught multiple courses across the organization to prepare nurses for successful participation in inquiry. She regularly serves as a mentor for nurses completing research, evidence-based practice, and quality improvement projects. Her areas of research interest include interventions to improve clinical outcomes for infants with neonatal abstinence syndrome, and interventions to promote the utilization of science in health care.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: April 6, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 1 Component(s)

    Does your health care organization standardize practice for IV push medication administration? Do you have ready-to-administer drugs available for patient care? Learn how ready-to-administer drugs can improve patient safety and nursing practice. Listen as Loretta Dorn discusses the importance of standardizing IV push medication administration utilizing INS Infusion Therapy Standards of Practice, and guidance provided by Institute for Safe Medical Practices (ISMP) and Quality and Safety Education for Nurses (QSEN).

    image

    Does your health care organization standardize practice for IV push medication administration? Do you have ready-to-administer drugs available for patient care? Learn how ready-to-administer drugs can improve patient safety and nursing practice. Listen as Loretta Dorn discusses the importance of standardizing IV push medication administration utilizing INS Infusion Therapy Standards of Practice, and guidance provided by Institute for Safe Medical Practices (ISMP) and Quality and Safety Education for Nurses (QSEN).

    Loretta Dorn, RN, MSN, CRNI®

    Director, Clinical Liaison Team

    Fresenius Kabi

    Loretta Dorn, RN MSN CRNI®, is the director of the clinical liaison team at Fresenius Kabi that provides professional education on the use and administration of IV therapy products to clinicians across the United States. She has more than 20 years of nursing experience and health care leadership experience in a variety of settings including community health, ICU, oncology, specialty IV therapy, home care, and long-term care. Loretta Dorn has written international health care standards and directed clinical studies, and is the patient safety chair of Quality and Safety Education for Nurses (QSEN). This team most recently published the IV Push Evidence-Based Practice Checklist. She has authored numerous publications in professional nursing and medical journals and works closely with professional organizations to assist with setting clinical standards. She is a peer journal reviewer for the Journal of Infusion Nursing and is on the American Academy of Medical-Surgical Nurses (AMSN) education committee. 

    Host: Dawn Berndt, DNP, RN, CRNI® - Clinical Education and Publications Manager

    Guest: Loretta Dorn, RN MSN CRNI®, Director of Clinical Liaisons – Fresenius Kabi US LLC

    Does your health care organization standardize practice for IV push medication administration? Do you have ready-to-administer drugs available for patient care? Learn how ready-to-administer drugs can improve patient safety and nursing practice. Listen as Loretta Dorn discusses the importance of standardizing IV push medication administration utilizing INS Infusion Therapy Standards of Practice, and guidance provided by Institute for Safe Medical Practices (ISMP) and Quality and Safety Education for Nurses (QSEN).

    Resources:

    ·      Home - Fresenius Kabi USA (fresenius-kabi.com)

    ·      Ready-to-Administer Drugs - Fresenius Kabi USA (fresenius-kabi.com)

    ·      Home | Institute For Safe Medication Practices (ismp.org)

    ·      Safe Practice Guidelines for Adult IV Push Medications | Institute For Safe Medication Practices (ismp.org)

    ·      QSEN Home –

    ·      IV Push Evidence-Based Practice Checklist - (qsen.org)

  • Contains 3 Component(s), Includes Credits Recorded On: 03/16/2022

    ​Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Many people do not understand what is happening with peripheral intravenous catheters (PIVCs), a seemingly innocuous device. Did you know that up to 69% of all PIVCs fail with an estimated excessive cost of $475,000 per 10,000 catheters used?—And the financial burden is only part of the story. Patient complications from PIVCs was number nine in the top 10 patient safety concerns in 2021, as identified by the ECRI Institute, one of the largest health care quality and safety entities in the world. To an observer, PIVCs often lie: we see no external signs and symptoms, and thus complications are often undetected. Yet when we look inside the vein, we see complications have begun, and we find the internal catheter positioning (the lie of the catheter) a contributing factor. Join us as we explore why the complications we see with PIVCs are late signs and symptoms of where the true problems lie.

    Learning Objectives:  At the conclusion of this presentation, learners will be able to:

    ·       Identify the prevalence of PIVC use and associated complications

    ·       Describe visually the impact of cannulation on vascular anatomy with use of case studies

    ·       Discuss the relationship between reported incidence of complications and actual practice

    ·       Summarize both the financial cost and patient outcomes involved with poor PIVC care

    ·       Discuss implementation in practice from the current INS Standards of Practice regarding PIVC placement and management

    S. Matthew Gibson, RN, CRNI®, VA-BC, CPUI

    CEO

    Vacllc

    Over the past decade, Matt has served national and local vascular access organizations, assumed leadership positions in multiple committees as a resident advisor, and been a published author in the area of vascular access. Currently Matt works as a vascular access consultant and speaker for various organizations. Matt is a certified registered nurse in infusion, is vascular access board certified, and is a certified PICC ultrasound user. He serves on the Association for Vascular Access (AVA) PIV Task Force and the AVA Public Policy Task Force, and is the CEO of Vascular Access Consulting LLC as well as the current president and founder of the Kentucky Indiana Vascular Access Network.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: March 16, 2025

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Contains 1 Component(s)

    Stewardship: The responsible overseeing and protection of something considered worth caring for and preserving. Antimicrobials are worth protecting to preserve their efficacy. Listen as Dr. Becky Linn discusses the antimicrobial stewardship, the drug development and resistance timeline, and educating patients regarding the effective use of antimicrobials.

    Stewardship: The responsible overseeing and protection of something considered worth caring for and preserving. Antimicrobials are worth protecting to preserve their efficacy. Listen as Dr. Becky Linn discusses the antimicrobial stewardship, the drug development and resistance timeline, and educating patients regarding the effective use of antimicrobials.

    Becky Linn, PharmD, BCPS

    Becky S. Linn, PharmD, BCPS, received her Doctor of Pharmacy from the University of Wyoming School of Pharmacy where she joined the faculty in 2013 teaching courses in therapeutics and clinical pharmacokinetics. After training at Poudre Valley Hospital in Fort Collins, Colorado, she practiced clinical pharmacy with an emphasis in critical care and student rotation coordination. Dr. Linn’s current practice involves daily rounding with an inpatient family medicine team for the Fort Collins Family Medicine Residency program. She serves as Champion of the Residency Teaching Certificate for the School of Pharmacy and is a member of the Student Affairs and Faculty Development Committees. Dr. Linn’s teaching interests include infectious diseases and cardiology, and her research interests include infectious diseases and interprofessional education models.

    Host: Dawn Berndt, DNP, RN, CRNI® - Clinical Education and Publications Manager

    Guest: Becky S. Linn, Pharm.D., BCPS - Associate Clinical Professor, University of Wyoming School of Pharmacy

    Stewardship: The responsible overseeing and protection of something considered worth caring for and preserving. Antimicrobials are worth protecting to preserve their efficacy. Listen as Dr. Becky Linn discusses the antimicrobial stewardship, the drug development and resistance timeline, and educating patients regarding the effective use of antimicrobials.

    Resources:

    About Antibiotic Resistance | CDC

    5 Things to Know | CDC

    Actions to Fight Antibiotic Resistance | CDC

    ANA-CDC-whitepaper.pdf – Redefining the Antibiotic Stewardship Team

    ANA white paper on antiobiotic stewardship - WSNA